title: The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding.
abstract: Cartilage oligomeric matrix protein (COMP), or thrombospondin-5 (TSP-5), is a secreted glycoprotein that is important for growth plate organization and function. Mutations in COMP cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (EDM1). In this study, we determined the structure of a recombinant protein that contains the last epidermal growth factor repeat, the type 3 repeats and the C-terminal domain (CTD) of COMP to 3.15-A resolution limit by X-ray crystallography. The CTD is a beta-sandwich that is composed of 15 antiparallel beta-strands, and the type 3 repeats are a contiguous series of calcium binding sites that associate with the CTD at multiple points. The crystal packing reveals an exposed potential metal-ion-dependent adhesion site (MIDAS) on one edge of the beta-sandwich that is common to all TSPs and may serve as a binding site for collagens and other ligands. Disease-causing mutations in COMP disrupt calcium binding, disulfide bond formation, intramolecular interactions, or sites for potential ligand binding. The structure presented here and its unique molecular packing in the crystal identify potential interactive sites for glycosaminoglycans, integrins, and collagens, which are key to cartilage structure and function.
authors.affiliation: Midwest Center for Structural Genomics, Biosciences Division, Argonne National Laboratory, Argonne, Illinois, USA.
authors.forename: Kemin
authors.initials: K
authors.lastname: Tan
authors.forename: Mark
authors.initials: M
authors.lastname: Duquette
authors.forename: Andrzej
authors.initials: A
authors.lastname: Joachimiak
authors.forename: Jack
authors.initials: J
authors.lastname: Lawler
mesh_terms: D001483:Base Sequence; D001665:Binding Sites; D064236:Cartilage Oligomeric Matrix Protein; D003094:Collagen / Q000378:metabolism; D018360:Crystallography, X-Ray; D003545:Cysteine / Q000737:chemistry; D018076:DNA, Complementary / Q000235:genetics; D016326:Extracellular Matrix Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D006023:Glycoproteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D016023:Integrins / Q000378:metabolism; D008024:Ligands; D064235:Matrilin Proteins; D008958:Models, Molecular; D009154:Mutation; D009842:Oligopeptides / Q000737:chemistry; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D055672:Static Electricity; D019700:Thrombospondin 1 / Q000737:chemistry; D019699:Thrombospondins / Q000737:chemistry; D000099262:Thrombospondin 2
chemical_list: D064236:Cartilage Oligomeric Matrix Protein; D003094:Collagen; D003545:Cysteine; D018076:DNA, Complementary; D016326:Extracellular Matrix Proteins; D006023:Glycoproteins; D006025:Glycosaminoglycans; D016023:Integrins; D008024:Ligands; D064235:Matrilin Proteins; D009842:Oligopeptides; D011994:Recombinant Proteins; D019700:Thrombospondin 1; D019699:Thrombospondins; D000099262:Thrombospondin 2; C577553:TSP5 protein, human; C047981:arginyl-glycyl-aspartic acid